Zivo Bioscience Inc (ZIVO)

$8

Market is closed - opens 7 PM, 15 Apr 2024

Insights on Zivo Bioscience Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 47.7% return, outperforming this stock by 102.0%

Performance

  • $7.16
    $8.00
    $8.00
    downward going graph

    10.54%

    Downside

    Day's Volatility :10.54%

    Upside

    0.0%

    downward going graph
  • $0.48
    $13.00
    $8.00
    downward going graph

    94.0%

    Downside

    52 Weeks Volatility :96.31%

    Upside

    38.46%

    downward going graph

Returns

PeriodZivo Bioscience IncIndex (Russel 2000)
3 Months
79.78%
0.0%
6 Months
70.72%
0.0%
1 Year
-54.34%
-0.7%
3 Years
-68.18%
-21.3%

Highlights

Market Capitalization
22.2M
Book Value
- $0.93
Earnings Per Share (EPS)
-4.6
PEG Ratio
0.0
Wall Street Target Price
15.0
Profit Margin
0.0%
Operating Margin TTM
-16072.75%
Return On Assets TTM
-338.92%
Return On Equity TTM
-3956.02%
Revenue TTM
27.7K
Revenue Per Share TTM
0.02
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
20.0K
Diluted Eps TTM
-4.6
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Zivo Bioscience Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 87.5%

Current $8.00
Target $15.00

Technicals Summary

Sell

Neutral

Buy

Zivo Bioscience Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Zivo Bioscience Inc
Zivo Bioscience Inc
-10.11%
70.72%
-54.34%
-68.18%
-68.18%
Moderna, Inc.
Moderna, Inc.
1.62%
14.36%
-33.07%
-34.3%
306.89%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-5.67%
7.24%
9.09%
88.02%
140.93%
Novo Nordisk A/s
Novo Nordisk A/s
-7.48%
23.09%
47.7%
252.97%
394.48%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
-2.99%
6.03%
18.9%
82.63%
117.3%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Zivo Bioscience Inc
Zivo Bioscience Inc
NA
NA
0.0
0.0
-39.56
-3.39
NA
-0.93
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.2
-0.29
-0.12
NA
36.27
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
26.28
26.28
1.51
44.87
0.16
0.08
NA
242.47
Novo Nordisk A/s
Novo Nordisk A/s
46.32
46.32
2.38
3.35
0.88
0.23
0.01
23.9
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
28.64
28.64
0.54
16.78
0.23
0.13
NA
68.22
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Zivo Bioscience Inc
Zivo Bioscience Inc
Buy
$22.2M
-68.18%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$41.0B
306.89%
24.73
-68.84%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$100.2B
140.93%
26.28
30.14%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$565.1B
394.48%
46.32
36.03%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$102.8B
117.3%
28.64
36.68%

Institutional Holdings

  • BARTLETT & Co WEALTH MANAGEMENT LLC

    0.01%

Company Information

zivo bioscience, inc., a u.s.-based r&d firm, is dedicated to the study, development and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains.

Organization
Zivo Bioscience Inc
Employees
8
CEO
Mr. John B. Payne
Industry
Consumer Non-Durables

FAQs